Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-12 5:05 pm Unchanged | 2024-01-11 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco LP | 2,301,955 6.200% | 0 (Unchanged) | Filing History |
| 2024-01-12 3:36 pm Purchase | 2024-01-11 | 13G | Solid Biosciences Inc. SLDB | Flynn James E | 2,260,398 6.080% | 2,260,398 (New Position) | Filing History |
| 2024-01-11 5:24 pm Purchase | 2024-01-11 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT LLC | 4,348,828 11.700% | 917,210 (+26.73%) | Filing History |
| 2024-01-10 4:31 pm Unchanged | 2024-01-08 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco LP | 2,301,955 11.400% | 0 (Unchanged) | Filing History |
| 2023-02-13 4:39 pm Sale | 2022-12-31 | 13G | Solid Biosciences Inc. SLDB | K2 PRINCIPAL FUND L.P. | 284,871 1.460% | -95,742 (-25.15%) | Filing History |
| 2023-02-13 08:45 am Unchanged | 2022-12-31 | 13G | Solid Biosciences Inc. SLDB | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-09 5:55 pm Sale | 2022-12-31 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital LLC | 0 0.000% | -613,513 (Position Closed) | Filing History |
| 2023-02-03 4:31 pm Unchanged | 2023-02-01 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 3,501,265 17.900% | 0 (Unchanged) | Filing History |
| 2022-12-12 09:50 am Purchase | 2022-12-02 | 13G | Solid Biosciences Inc. SLDB | Camber Capital Management LLC | 1,418,440 7.260% | 1,418,440 (New Position) | Filing History |
| 2022-12-06 4:30 pm Purchase | 2022-12-02 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 3,501,265 17.900% | 2,603,762 (+290.11%) | Filing History |
| 2022-12-05 5:12 pm Purchase | 2022-12-02 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT LLC | 3,431,618 17.570% | 2,601,760 (+313.52%) | Filing History |
| 2022-12-05 4:28 pm Purchase | 2022-12-02 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco LP | 2,301,955 11.800% | 1,773,294 (+335.43%) | Filing History |
| 2022-10-04 5:14 pm Unchanged | 2022-09-29 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT LLC | 829,858 11.010% | 0 (Unchanged) | Filing History |
| 2022-10-03 5:11 pm Unchanged | 2022-09-29 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco LP | 528,661 7.000% | 0 (Unchanged) | Filing History |
| 2022-09-06 4:50 pm Purchase | 2022-09-02 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT LLC | 829,858 11.010% | 5,333 (+0.65%) | Filing History |
| 2022-09-02 4:50 pm Purchase | 2022-09-02 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 897,503 11.900% | 3,333 (+0.37%) | Filing History |
| 2022-08-31 5:49 pm Purchase | 2022-08-29 | 13G | Solid Biosciences Inc. SLDB | K2 PRINCIPAL FUND L.P. | 380,613 5.050% | 380,613 (New Position) | Filing History |
| 2022-08-18 4:55 pm Unchanged | 2022-08-18 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco LP | 528,661 7.000% | 0 (Unchanged) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Solid Biosciences Inc. SLDB | BlackRock Inc. BLK | 191,242 2.500% | -225,638 (-54.13%) | Filing History |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | Boxer Capital LLC | 355,735 4.700% | -57,615 (-13.94%) | Filing History |